Granahan Investment Management LLC Sells 4,086 Shares of iRadimed Corporation $IRMD

Key Points

• Granahan Investment Management LLC reduced its stake in iRadimed Corporation by 32.3%, selling 4,086 shares, and now holds approximately 8,559 shares valued at $449,000.
• iRadimed recently announced a quarterly dividend of $0.17 per share, reflecting an annualized dividend of $0.68 with a yield of 0.9%.
• The company's stock price opened at $71.99 and has seen a twelve-month high of $74.00 and a low of $44.58.

Granahan Investment Management LLC cut its holdings in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) by 32.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,559 shares of the medical equipment provider's stock after selling 4,086 shares during the period. Granahan Investment Management LLC owned about 0.07% of iRadimed worth $449,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. First Horizon Advisors Inc. grew its holdings in iRadimed by 78.7% during the 1st quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock worth $27,000 after acquiring an additional 226 shares during the last quarter. US Bancorp DE grew its holdings in iRadimed by 132.7% during the 1st quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock worth $75,000 after acquiring an additional 819 shares during the last quarter. Quantbot Technologies LP bought a new stake in iRadimed during the 1st quarter worth about $78,000. Comerica Bank grew its holdings in iRadimed by 21.4% during the 1st quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock worth $120,000 after acquiring an additional 404 shares during the last quarter. Finally, State of Wyoming bought a new stake in iRadimed during the 4th quarter worth about $149,000. 92.34% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other iRadimed news, Director Monty K. Allen sold 1,102 shares of the stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $69.10, for a total transaction of $76,148.20. Following the sale, the director owned 19,898 shares of the company's stock, valued at $1,374,951.80. This represents a 5.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 36.80% of the stock is currently owned by corporate insiders.

iRadimed Stock Down 0.2%

NASDAQ:IRMD traded down $0.12 during mid-day trading on Wednesday, reaching $71.77. 32,232 shares of the company were exchanged, compared to its average volume of 44,211. iRadimed Corporation has a 12 month low of $45.89 and a 12 month high of $74.00. The company has a fifty day moving average of $65.43 and a 200 day moving average of $58.12. The stock has a market cap of $912.91 million, a PE ratio of 44.30 and a beta of 1.02.

iRadimed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a yield of 0.9%. iRadimed's dividend payout ratio is currently 41.98%.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.